-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Unknowns of Gene Therapy and Successes of Medical Therapies for Hemophilia A

Program: Spotlight Sessions
Session: Gene Therapy and Hemophilia A: What Is the Future of Curative Therapy in the Age of Emicizumab?
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Hemophilia, Diseases
Monday, December 9, 2024, 2:45 PM-4:00 PM

Christine L Kempton, MD

Emory University, Atlanta, GA

Disclosures: Kempton: Biomarin: Honoraria; Genentech, Inc: Honoraria.

See more of: Gene Therapy and Hemophilia A: What Is the Future of Curative Therapy in the Age of Emicizumab?
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation